Illumina, AbbVie, Abbott Laboratories, Qiagen, and Eli Lilly are major players in the US personalized medicine market and are investing in related R&D.
1 report, 1 independent
Updated Aug 12
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Illumina, AbbVie, Abbott Laboratories, Qiagen, and Eli Lilly are major players in the US personalized medicine market and are investing in related R&D.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Market growth in personalized medicine is being driven by demand, involving major players like Roche and Illumina.Sub-event
Five companies are major players in the US personalized medicine market.1 source
Keep exploring
The entities involved
-
AbbVie
pharmaceutical company
-
Illumina
American company that develops systems for the analysis of genetic variation
-
Abbott Laboratories
American global health care and medical device products company
-
Qiagen
company
Nothing else this week.
Related events
- Market pressure due to cost trends is affecting major companies including UnitedHealth Group, Molina Healthcare, Abbott Laboratories, and Eli Lilly, as reported on Investopedia.
- Several healthcare ETFs hold major pharmaceutical companies like Eli Lilly, J&J, and Novo Nordisk as top 3 positions, leading to competition for investor capital.
- Syndax Pharmaceuticals and AbbVie are competing in the healthcare and biopharma sector.
- AbbVie and Boehringer Ingelheim are engaging with financial advisory firms regarding potential deals and discussing M&A strategies in the competitive pharmaceutical market.
- AbbVie, AstraZeneca, and GSK are major players in global drug development, facing challenges in the drug class and pursuing licensing deals with Chinese biotechs.
Coverage
Newest first; wire copies grouped- GlobeNewswireUS Personalized Medicine Market Trends and Company Analysis Report 2025-2033 Featuring Abbott, GE, Aadi Bioscience, Illumina, QIAGEN, Eli Lilly and Co, Takeda, AbbVie, F. Hoffmann-La Roche The United